Register of Telaprevir and Boceprevir in Routine Clinical Practice

Sponsor
Fundación Pública Andaluza Progreso y Salud (Other)
Overall Status
Completed
CT.gov ID
NCT02004379
Collaborator
(none)
1,553
48
19
32.4
1.7

Study Details

Study Description

Brief Summary

Know through routine clinical practice the effectiveness and safety of current treatment of hepatitis C virus, genotype 1, for patients who have never been treated and for patients who have been previously treated

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    1553 participants
    Observational Model:
    Cohort
    Study Start Date :
    Nov 1, 2013
    Actual Primary Completion Date :
    Jun 1, 2015
    Actual Study Completion Date :
    Jun 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    Patients with hepatitis C, genotype 1

    Patients with hepatitis C, genotype 1, treated with telaprevir or boceprevir

    Outcome Measures

    Primary Outcome Measures

    1. Effectiveness of current treatment of hepatitis C virus, genotype 1, for patients who have never been treated and for patients who have been previously treated [12 months]

      Know through routine clinical practice the percentage of patients who have negative VHC-ARN

    2. Safety of current treatment of hepatitis C virus, genotype 1, for patients who have never been treated and for patients who have been previously treated [12 months]

      Number and frequencies of serious adverse event (SAE) during the treatment

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients infected by hepatitis C virus, genotype 1

    • Indication of treatment with telaprevir or boceprevir in F3 and F4 fibrosis

    Exclusion Criteria:
    • Being taking part in other

    • Inability to follow a monitoring

    • Contra-indications on triple therapy

    • Coinfected with HIV and HBV (hepatitis B virus)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Universitario Doctor Negrín Las Palmas de Gran Canaria Gran Canaria Spain
    2 Hospital Comarcal Santa Ana Motril Granada Spain
    3 Hospital Universitario de Santiago de Compostela Santiago de Compostela La Coruña Spain
    4 Hospital Universitario Fundación Alcorcón Alcorcón Madrid Spain
    5 Hospital Son Espases Palma de Mallorca Mallorca Spain
    6 Hospital General Universitario Rafael Méndez Lorca Murcia Spain
    7 Agencia Sanitaria Costa del Sol Marbella Málaga Spain
    8 Hospital Universitario Nuestra Señora de la Candelaria Santa Cruz de Tenerife Tenerife Spain
    9 Hospital de Poniente Almería Spain
    10 Hospital Torrecárdenas Almería Spain
    11 Hospital Infanta Cristina Badajoz Spain
    12 Hospital Universitario de Cruces Bilbao Spain
    13 Hospital General de Ciudad Real Ciudad Real Spain
    14 Hospital San Pedro de Alcántara Cáceres Spain
    15 Hospital Puerta del Mar Cádiz Spain
    16 Hospital Reina Sofía Córdoba Spain
    17 Hospital Universitario de San Cecilio Granada Spain
    18 Hospital Universitario Virgen de las Nieves Granada Spain
    19 Hospital de Guadalajara Guadalajara Spain
    20 Hospital Juan Ramón Jiménez Huelva Spain
    21 Hospital San Jorge Huesca Spain
    22 Complejo Hospitalario de Jaén Jaén Spain
    23 Hospital Universitario A Coruña La Coruña Spain
    24 Hospital de León León Spain
    25 Hospital Ramón y Cajal Madrid Spain
    26 Hospital Universitario de La Princesa Madrid Spain
    27 Hospital Universitario La Paz Madrid Spain
    28 Hospital Morales Meseguer Murcia Spain
    29 Hospital Reina Sofía Murcia Spain
    30 Hospital Universitario Virgen de la Arrixaca Murcia Spain
    31 Hospital Universitario Carlos Haya Málaga Spain
    32 Hospital Universitario Virgen de la Victoria Málaga Spain
    33 Hospital Universitario Central de Asturias Oviedo Spain
    34 Hospital Universitario de Salamanca Salamanca Spain
    35 Hospital Universitario de Donostia San Sebastián Spain
    36 Hospital Universitario de Valme Sevilla Spain
    37 Hospital Universitario Virgen de la Macarena Sevilla Spain
    38 Hospital Unviersitario Virgen del Rocío Sevilla Spain
    39 Complejo Hospitalario de Toledo Toledo Spain
    40 Hospital Arnau de Vilanova Valencia Spain
    41 Hospital Clínico de Valencia Valencia Spain
    42 Hospital General de Valencia Valencia Spain
    43 Hospital la Fe Valencia Spain
    44 Hospital Clínico Universitario de Valladolid Valladolid Spain
    45 Hospital Universitario Río Hortega Valladolid Spain
    46 Hospital de Zamora Zamora Spain
    47 Hospital Clínico Universitario de Zaragoza Zaragoza Spain
    48 Hospital Universitario Miguel Servet Zaragoza Spain

    Sponsors and Collaborators

    • Fundación Pública Andaluza Progreso y Salud

    Investigators

    • Principal Investigator: Javier Salmerón Escobar, Hospital Universitario de San Cecilio

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Fundación Pública Andaluza Progreso y Salud
    ClinicalTrials.gov Identifier:
    NCT02004379
    Other Study ID Numbers:
    • FPS-TEL-2013-01
    First Posted:
    Dec 9, 2013
    Last Update Posted:
    Jul 15, 2015
    Last Verified:
    Jul 1, 2015
    Keywords provided by Fundación Pública Andaluza Progreso y Salud
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 15, 2015